Cardiovascular Agents

Multum Therapeutic Class Comparison, United States, 2022

Total Prescriptions in (2022)

Drug Name	Total Prescriptions (2022)	Percent Share
Lisinopril	82,513,968	16.3%
Amlodipine	70,766,211	14%
Metoprolol	65,245,217	12.9%
Losartan	53,555,511	10.6%
Hydrochlorothiazide	38,153,288	7.5%
Furosemide	23,067,424	4.6%
Carvedilol	17,067,595	3.4%
Spironolactone	12,450,600	2.5%
Hydrochlorothiazide; Lisinopril	12,335,356	2.4%
Atenolol	10,675,235	2.1%
Clonidine	9,626,081	1.9%
Hydrochlorothiazide; Losartan	8,825,879	1.7%
Propranolol	8,810,847	1.7%
Olmesartan	6,554,548	1.3%
Diltiazem	6,257,580	1.2%
Chlorthalidone	5,928,576	1.2%
Hydrochlorothiazide; Triamterene	5,500,904	1.1%
Valsartan	5,450,867	1.1%
Isosorbide	5,429,186	1.1%
Hydralazine	5,298,188	1%
Enalapril	4,066,368	0.8%
Nifedipine	3,681,538	0.7%
Sildenafil	3,459,591	0.7%
Benazepril	3,424,800	0.7%
Sacubitril; Valsartan	3,183,215	0.6%
Amlodipine; Benazepril	3,083,303	0.6%
Tadalafil	3,024,681	0.6%
Nebivolol	3,006,295	0.6%
Doxazosin	2,644,459	0.5%
Torsemide	2,524,293	0.5%
Ramipril	2,404,446	0.5%
Verapamil	2,384,034	0.5%
Nitroglycerin	2,158,295	0.4%
Irbesartan	2,067,518	0.4%
Labetalol	1,789,474	0.4%
Telmisartan	1,577,535	0.3%
Ranolazine	1,543,317	0.3%
Hydrochlorothiazide; Olmesartan	1,512,684	0.3%
Amiodarone	1,501,095	0.3%
Epinephrine	1,458,094	0.3%
Bisoprolol	1,295,378	0.3%
Guanfacine	828,447	0.2%

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2013-2022. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Mailing List

Get Email Updates

New and Popular

Open Menu

Cite This Page

Show AMA citation

Biostatistics Rx - ESCAPE THE CLASSROOM - Learn biostatistics at your own pace, on your own time, with engaging high-def videos

Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021

Top